Wells Fargo
GOSS icon

Wells Fargo’s Gossamer Bio GOSS Stock Holding History

Wells Fargo’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.1K Sell
76,264
-285,657
-79% -$449K ﹤0.01% 5694
2025
Q4 		$1.12M Buy
361,921
+245,254
+210% +$700K ﹤0.01% 3878
2025
Q3 		$307K Buy
116,667
+18,510
+19% +$40.8K ﹤0.01% 4664
2025
Q2 		$121K Buy
98,157
+93,751
+2,128% +$102K ﹤0.01% 5088
2025
Q1 		$4.85K Buy
+4,406
New +$5.09K ﹤0.01% 6035
2024
Q4 		– Sell
-264
Closed -$260 – 7115
2024
Q3 		$260 Sell
264
-136
-34% -$131 ﹤0.01% 6214
2024
Q2 		$360 Sell
400
-1,569
-80% -$1.17K ﹤0.01% 6169
2024
Q1 		$2.32K Buy
1,969
+26
+1% +$29 ﹤0.01% 6005
2023
Q4 		$1.77K Buy
1,943
+80
+4% +$59 ﹤0.01% 6121
2023
Q3 		$1.55K Buy
1,863
+899
+93% +$1.04K ﹤0.01% 6132
2023
Q2 		$1.16K Sell
964
-11,706
-92% -$14.6K ﹤0.01% 6293
2023
Q1 		$16K Buy
+12,670
New +$24.3K ﹤0.01% 5713
2022
Q4 		– Sell
-3,335
Closed -$39K – 7561
2022
Q3 		$39K Sell
3,335
-446
-12% -$5.54K ﹤0.01% 5064
2022
Q2 		$31K Sell
3,781
-3,192
-46% -$24.7K ﹤0.01% 5250
2022
Q1 		$60K Sell
6,973
-21,241
-75% -$205K ﹤0.01% 5564
2021
Q4 		$319K Buy
28,214
+12,525
+80% +$149K ﹤0.01% 5005
2021
Q3 		$198K Buy
15,689
+179
+1% +$1.65K ﹤0.01% 5100
2021
Q2 		$126K Sell
15,510
-4,159
-21% -$36.1K ﹤0.01% 5210
2021
Q1 		$182K Sell
19,669
-38,309
-66% -$386K ﹤0.01% 5199
2020
Q4 		$560K Buy
57,978
+17,831
+44% +$176K ﹤0.01% 4438
2020
Q3 		$497K Sell
40,147
-15,268
-28% -$202K ﹤0.01% 4341
2020
Q2 		$721K Buy
55,415
+13,018
+31% +$164K ﹤0.01% 4068
2020
Q1 		$430K Buy
42,397
+18,124
+75% +$237K ﹤0.01% 4153
2019
Q4 		$380K Sell
24,273
-92
-0.4% -$1.85K ﹤0.01% 4571
2019
Q3 		$409K Sell
24,365
-1,213
-5% -$24.1K ﹤0.01% 4506
2019
Q2 		$568K Buy
25,578
+19,778
+341% +$378K ﹤0.01% 4287
2019
Q1 		$126K Buy
+5,800
New +$121K ﹤0.01% 5051

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Wells Fargo's GOSS Position: Q1 2026 in Review

Wells Fargo reduced its Gossamer Bio (GOSS) stake by 79% in Q1 2026, selling an estimated $449K and leaving 76,264 shares worth $25.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5694.

Wells Fargo first reported a position in GOSS in Q1 2019 and has held it in 27 quarters since. The position peaked at $1.12M in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Wells Fargo held 76,264 shares of Gossamer Bio worth $25.1K as of Q1 2026.
  • Wells Fargo sold 285,657 Gossamer Bio shares in Q1 2026, an estimated $449K.
  • Gossamer Bio made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5694 holding.
  • Wells Fargo first reported a position in Gossamer Bio in Q1 2019 and has held it in 27 quarters since.
  • Wells Fargo's Gossamer Bio position peaked at $1.12M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.